A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(41 sites)

China

The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei, Anhui

The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui

Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality

Beijing Youan Hospital, Capital Medical University, Beijing, Beijing Municipality

China-Japan Friendship Hospital, Beijing, Beijing Municipality